Antihypertensive agents
Patent 4026894 Issued on May 31, 1977. Estimated Expiration Date: 
May 31, 1994. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
May 31, 1994. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent References 3511836 3920636 InventorsAssigneeApplicationNo. 05/621980 filed on 10/14/1975US Classes:544/291, Nitrogen bonded directly at 2- and 4-positions544/374Ring chalcogen in the additional hetero ringExaminersPrimary: Coughlan, Paul M. Jr.Attorney, Agent or FirmAbstractDescribed are antihypertensive agents selected from the class consisting of 2[4(tetrahydro-2-furoyl)-piperazino]-4-amino-6,7-dimethoxyquinazoline and 2-[4(tetrahydropyran-2-carbonyl)-piperazinyl]-4-amino-6,7-dimethoxyquinazo line, and pharmaceutically acceptable acid addition salts thereof. The compounds are highly water soluble and can be administered in time release form as well as parenterally, including intravenously. |
| ||||||||||||||
